Office of Nonprescription Drugs
The Office of Non-Prescription Drugs (ONPD) consists of two review divisions: The Division of Nonprescription Drugs I and Nonprescription Drugs II. The Immediate office oversees the development, review, and regulation of nonprescription products (marketed under Over-the-counter (OTC) monographs and under NDAs) reviewed in these divisions. OTC drugs play an increasingly vital role in America's health care system.
Director: Karen Murry, M.D.
Acting Deputy Director: Pamela Horn, M.D.
Associate Director for Stakeholder Affairs: Andrea Frydl, MHS, MBA
Associate Director for Nonprescription Regulatory and Scientific Affairs: Phong Pham, Pharm.D., M.B.A.
Regulatory Operations
Director of Project Management Staff: Celia Peacock, MPH
Contact Us
Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Nonprescription Drugs
10903 New Hampshire Avenue WO22 Stop 5411
Silver Spring, MD 20993
301-796-0138
Resources For You
- Over-the-Counter OTC | Nonprescription Drugs
- Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act
- OTC Monographs @ FDA
- Over-The-Counter Monograph Drug User Fee Program